captured official filings
Anebulo Pharmaceuticals, Inc.
Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.
captured official filings
captured official filings
captured official filings
One evidence index instead of a manual filing hunt.
It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.
What teams can pay to automate next.
Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.
Public registration text delta
Comparing S-1 filed 2022-11-02 with S-1/A filed 2021-05-05.
Tracked-term count changes
Counts are navigation signals, not conclusions. Open both official filings to determine materiality.
- shares79 → 45-34
- offering38 → 58+20
- control6 → 19+13
- management6 → 17+11
- dilution0 → 7+7
- proceeds12 → 14+2
Candidate disclosure excerpts
Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.
- SUBJECT TO COMPLETION, DATED MAY 5, 2021 PRELIMINARY PROSPECTUS 3,000,000 Shares Anebulo Pharmaceuticals, Inc.
- Common Stock This is the initial public offering of common stock of Anebulo Pharmaceuticals, Inc.
- Prior to this offering, no public market has existed for our common stock.
- SUBJECT TO COMPLETION, DATED NOVEMBER 2, 2022 PROSPECTUS 4,529,300 shares of Common Stock This prospectus covers the offer and resale by the selling stockholders identified in this prospectus of up to an aggregate of 4,529,300 shares of our common stock, which includes 2,264,650 shares of our common stock and 2,264,650 shares of
- An aggregate of 2,264,650 shares of our common stock and warrants to purchase 2,264,650 shares of our common stock were sold to the selling stockholders in a private placement on September 28, 2022 (the “Private Placement”).
- We are not selling any shares of common stock under this prospectus and will not receive any proceeds from the sale by the selling stockholders of such shares.
Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.
Save a project-ready issuer record.
US$29 one time. No subscription and no account. You receive the current printable Evidence Snapshot in this browser immediately after verified payment.
- Source-linked filing chronology and registration path
- Machine-detected amendment and tracked-term change view
- Official-source index for project-file archiving and downloadable CSV export
Secure checkout by PayPal.
Save this source-linked record
Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.
Captured filing chronology
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- EFFECTRegistration & offeringOpen SEC filing →
- EFFECTRegistration & offeringOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- PRE 14AGovernanceOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- DEF 14AGovernanceOpen SEC filing →
- 424B5Registration & offeringOpen SEC filing →
- EFFECTRegistration & offeringOpen SEC filing →
- PRE 14AGovernanceOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.